Tomoko Namba, founder and board member of DeNA Co., speaks at a news conference at the University of Tokyo's Institute of Medical Science in Tokyo,...
{"Image ImageDescription": "Tomoko Namba, founder and board member of DeNA Co., speaks at a news conference at the University of Tokyo's Institute of Medical Science in Tokyo, Japan, on Wednesday, July 9, 2014. DeNA Life Science Inc., the healthcare subsidiary of DeNa, announced today the company's direct-to-consumer (DTC) genetic testing service \"Mycode\" will be launched in Japan in mid-August. Photographer: Kiyoshi Ota/Bloomberg via Getty Images", "Image Copyright": "? 2014 Bloomberg Finance LP"}